Skip to main content

Table 1 Baseline of patients with different OLA1 expression level

From: OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis

 

OLA1 Low

(N = 63)

OLA1 High

(N = 48)

p

Age

58.84 ± 14.21

49.56 ± 15.12

0.797

Gender

  

0.497

 Male

34(54.0%)

29(60.4%)

 

 Female

29(46.0%)

19(39.6%)

 

Tumor location

  

0.577

 Right colon

20(31.7%)

11(22.9%)

 

 Left colon

13(20.6%)

12(25.0%)

 

 Rectum

30(47.6%)

24(52.1%)

 

T stage

  

0.147

 T1

4(6.3%)

3(6.2%)

 

 T2

16(25.4%)

7(14.6%)

 

 T3

22(34.9%)

27(56.2%)

 

 T4

21(33.3%)

11(22.9%)

 

N stage

  

0.702

 N0

36(57.1%)

22(45.8%)

 

 N1

14(22.2%)

13(27.1%)

 

 N2a

4(6.3%)

4(8.3%)

 

 N2b

9(14.3%)

9(18.8%)

 

M stage

  

0.159

 M0

57(90.5%)

39(81.2%)

 

 M1

6(9.5%)

9(18.8%)

 

Tumor size

  

0.938

 ≤ 3 cm

17(27.0%)

14(29.2%)

 

 3-5 cm

31(49.2%)

22(45.8%)

 

 >5 cm

15(23.8%)

12(25.0%)

 

Tumor differentiation

  

0.425

 Poor

4(6.3%)

2(4.2%)

 

 Moderate

25(39.7%)

25(52.1%)

 

 Well

24(38.1%)

15(31.2%)

 

 Mucous

7(11.1%)

6(12.5%)

 

 Signet ring

3(4.8%)

0(0.0%)

 

Chemotherapy

  

0.721

 No

44(69.8%)

32(66.7%)

 

 Yes

19(30.2%)

16(33.3%)